Literature DB >> 22699883

TNFα regulates the localization of CD40 in lipid rafts of glioma cells.

Richa Tewari1, Saurav Roy Choudhury, Veer Singh Mehta, Ellora Sen.   

Abstract

Resistance of glioblastoma multiforme (GBM) to TNFα induced apoptosis is attributed to NFκB activation. As TNF-receptor family member CD40 regulates NFκB activation, we investigated the role of CD40 in NFκB activation in GBM. We observed elevated CD40 levels in human glioma samples as compared to the surrounding normal tissue. Treatment with TNFα elevated CD40 levels in glioma cells and inhibition of CD40 signaling failed to abrogate TNFα induced NFκΒ activity. While TNFα increased the interaction between TRAF2/6, IκBα, IKKα/β in the CD40 signalosome, the level of CD40 in the signalosome remained unaffected upon TNFα treatment. Interestingly, TNFα decreased the spatial localization of CD40 and increased TRAF2/6 co-localization with lipid raft marker Caveolin. As localization of CD40 signalosome in lipid raft is crucial for NFκB activation, TNFα mediated decreased clustering of CD40 in lipid rafts could have possibly contributed to its non-involvement in NFκB activation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22699883     DOI: 10.1007/s11033-012-1726-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  19 in total

1.  Expression of CD40 and growth-inhibitory activity of CD40 agonist in ovarian carcinoma cells.

Authors:  Yan Zhou; Jing He; Lan-tu Gou; Bo Mu; Wei-chan Liao; Cong Ma; Ping Tang; Shi-jie Zhou; Yong-jun Zhou; Jin-liang Yang
Journal:  Cancer Immunol Immunother       Date:  2012-03-11       Impact factor: 6.968

2.  Critical role of CD40-mediated autocrine tumor necrosis factor-alpha in potentiation of cisplatin-induced cytotoxicity in cancer cells.

Authors:  Hong Sun; Ying-Jia Zhong; Xue-Lian Zheng; Qiong Wang; Lan Yang; Fang Shi; Jia-Qi Yan; Fan He; Lin-Chuan Liao; Yong Lin; Lin Zhang; Xia Wang
Journal:  Cancer Sci       Date:  2011-11-17       Impact factor: 6.716

3.  Involvement of TNFα-induced TLR4-NF-κB and TLR4-HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma.

Authors:  Richa Tewari; Saurav Roy Choudhury; Sadashib Ghosh; Veer Singh Mehta; Ellora Sen
Journal:  J Mol Med (Berl)       Date:  2011-09-02       Impact factor: 4.599

4.  Ras regulates interleukin-1β-induced HIF-1α transcriptional activity in glioblastoma.

Authors:  Vivek Sharma; Deobrat Dixit; Nitin Koul; Veer Singh Mehta; Ellora Sen
Journal:  J Mol Med (Berl)       Date:  2010-09-24       Impact factor: 4.599

5.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

6.  Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines.

Authors:  M R Posner; L A Cavacini; M P Upton; K C Tillman; E R Gornstein; C M Norris
Journal:  Clin Cancer Res       Date:  1999-08       Impact factor: 12.531

7.  CD40 is a regulator for vascular endothelial growth factor in the tumor microenvironment of glioma.

Authors:  Fang Xie; Qin Shi; Qin Wang; Yan Ge; Yongjing Chen; Jianling Zuo; Yongping Gu; Haizhen Deng; Hui Mao; Zhenhua Hu; Yinghui Zhou; Xueguang Zhang
Journal:  J Neuroimmunol       Date:  2010-03-20       Impact factor: 3.478

8.  Ebselen sensitizes glioblastoma cells to Tumor Necrosis Factor (TNFalpha)-induced apoptosis through two distinct pathways involving NF-kappaB downregulation and Fas-mediated formation of death inducing signaling complex.

Authors:  Vivek Sharma; Richa Tewari; Ugir Hossain Sk; Christy Joseph; Ellora Sen
Journal:  Int J Cancer       Date:  2008-11-01       Impact factor: 7.396

9.  Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.

Authors:  M Tsujimoto; Y K Yip; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition.

Authors:  D Dixit; V Sharma; S Ghosh; V S Mehta; E Sen
Journal:  Cell Death Dis       Date:  2012-02-09       Impact factor: 8.469

View more
  7 in total

1.  Multiple steps determine CD73 shedding from RPE: lipid raft localization, ARA1 interaction, and MMP-9 up-regulation.

Authors:  Wei Zhang; Shumin Zhou; Guoping Liu; Fanqiang Kong; Song Chen; Hua Yan
Journal:  Purinergic Signal       Date:  2018-11-03       Impact factor: 3.765

2.  A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis.

Authors:  Xiangtai Wei; Duo Chen; Tao Lv
Journal:  Mol Biol Rep       Date:  2012-10-25       Impact factor: 2.316

3.  Genetic polymorphisms in XRCC1 gene and susceptibility to glioma in Chinese Han population.

Authors:  Zheng Jin; Haiyang Xu; Xianfeng Zhang; Gang Zhao
Journal:  Tumour Biol       Date:  2013-08-06

4.  Tumor targeting using magnetic nanoparticle Hsp70 conjugate in a model of C6 glioma.

Authors:  Maxim A Shevtsov; Ludmila Y Yakovleva; Boris P Nikolaev; Yaroslav Y Marchenko; Anatolii V Dobrodumov; Kirill V Onokhin; Yana S Onokhina; Sergey A Selkov; Anastasiia L Mikhrina; Irina V Guzhova; Marina G Martynova; Olga A Bystrova; Alexander M Ischenko; Boris A Margulis
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

5.  An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.

Authors:  Nardnisa Sintupisut; Pei-Ling Liu; Chen-Hsiang Yeang
Journal:  Nucleic Acids Res       Date:  2013-07-31       Impact factor: 16.971

6.  A methylation-driven gene panel predicts survival in patients with colon cancer.

Authors:  Yaojun Peng; Jing Zhao; Fan Yin; Gaowa Sharen; Qiyan Wu; Qi Chen; Xiaoxuan Sun; Juan Yang; Huan Wang; Dong Zhang
Journal:  FEBS Open Bio       Date:  2021-07-28       Impact factor: 2.693

7.  NF-κB pathway activators as potential ageing biomarkers: targets for new therapeutic strategies.

Authors:  Carmela R Balistreri; Giuseppina Candore; Giulia Accardi; Giuseppina Colonna-Romano; Domenico Lio
Journal:  Immun Ageing       Date:  2013-06-20       Impact factor: 6.400

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.